Earnings Feed
Start Free
ONYX PHARMACEUTICALS INC·4

Jul 2, 6:53 PM ET

ONYX PHARMACEUTICALS INC 4

4 · ONYX PHARMACEUTICALS INC · Filed Jul 2, 2013

Insider Transaction Report

Form 4
Period: 2013-07-01
ONYX PHARMACEUTICALS INCONXX
GODDARD PAUL
Director
Transactions
  • Sale

    Common Stock

    2013-07-01$131.92/sh−3,500$461,703→ 17,390 total
  • Exercise/Conversion

    Common Stock

    2013-07-01$28.41/sh+4,000$113,640→ 20,890 total
  • Sale

    Common Stock

    2013-07-01$132.63/sh−2,500$331,575→ 14,890 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-07-01−2,000→ 0 total
    Exercise: $12.50Exp: 2017-02-07→ Common Stock (2,000 underlying)
  • Exercise/Conversion

    Common Stock

    2013-07-01$12.50/sh+2,000$25,000→ 16,890 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-07-01−4,000→ 1,000 total
    Exercise: $28.41Exp: 2015-02-07→ Common Stock (4,000 underlying)
Footnotes (3)
  • [F1]Shares sold pursuant to 10b5-1 plan.
  • [F2]The shares were sold at prices ranging from $131.58 to $132.425. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Fully vested.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -